Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale Director sold 5,000 shares at $18.72 ($93,600)
  2. 4 Open-market sale Director sold 7,000 shares at $20.05 ($140,350)
  3. 4 Open-market sale SVP & Chief Scientific Officer sold 100,000 shares at $21.70 ($2,170,000)
  4. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 180,000 shares at $21.70 ($3,906,000)
  5. 4 Open-market sale Director sold 15,000 shares at $21.88 ($328,200)
  6. 4 Open-market sale SVP & Chief Accounting Officer sold 112,500 shares at $19.69 ($2,215,125)
  7. 4 Exercise or conversion Director acquired 14,000 shares (option exercise)
  8. 4 Open-market sale Director sold 5,000 shares at $15.41 ($77,050)
  9. 4 Open-market sale SVP & Chief Financial Officer sold 200,000 shares at an average $15.16 ($3,031,950)
  10. 4 Open-market sale Director sold 30,000 shares at $13.08 ($392,400)
  11. 4 Open-market sale SVP & Chief Accounting Officer sold 1,965 shares at $13.14 ($25,820)
  12. 4 Open-market sale President & CEO sold 8,636 shares at $13.14 ($113,477)
  13. 4 Open-market sale SVP & Chief Operating Officer sold 3,237 shares at $13.14 ($42,534)
  14. 4 Open-market sale SVP & Chief Financial Officer sold 2,359 shares at $13.14 ($30,997)
  15. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 2,195 shares at $13.14 ($28,842)
  16. 4 Open-market sale SVP & Chief Medical Officer sold 1,457 shares at $13.14 ($19,145)
  17. 4 Open-market sale SVP & Chief Scientific Officer sold 1,261 shares at $13.14 ($16,570)
  18. 4 Exercise or conversion SVP & Chief Operating Officer acquired 45,000 shares (option exercise)
  19. 4 Open-market sale President & CEO sold 87,500 shares at $13.04 ($1,141,000)
  20. 4 Open-market sale SVP & Chief Operating Officer sold 75,000 shares at an average $12.39 ($929,351)

Page 22 of 49 · 970 filings